We are live on ! Find out more
XBIO icon

Xenetic Biosciences
XBIO

6 hedge funds and large institutions have $453K invested in Xenetic Biosciences in 2026 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 6 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

83% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 6

Holders
6
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$19.4K

Top Sellers

1
-$101K
2
-$32.3K
3
-$30K
4
TRCT
Tower Research Capital (TRC)
New York
-$7.91K
5
Citigroup
Citigroup
New York
-$2.69K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$368K
Geode Capital Management
2
Geode Capital Management
Massachusetts
$57.5K
VCM
3
Vanguard Capital Management
Pennsylvania
$18K
JEST
4
JTC Employer Solutions Trustee
Jersey
$7K
TRCT
5
Tower Research Capital (TRC)
New York
$2.16K
DWM
6
Darwin Wealth Management
Florida
$5
Citadel Advisors
7
Citadel Advisors
Florida
–
DS
8
DRW Securities
Illinois
–
Citigroup
9
Citigroup
New York
–
AIP
10
Alexis Investment Partners
Texas
–
Bank of America
11
Bank of America
North Carolina
–
Morgan Stanley
12
Morgan Stanley
New York
–